Table 2. .
Percentage of Cohort with HBD-2 Gene Copy Number of |
|||||||||
Cohort | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
Control: | |||||||||
Cleveland | 5.0 | 15.0 | 45.0 | 25.0 | 5.0 | 5.0 | |||
Europe | 2.7 | 23.5 | 38.3 | 23.5 | 10.1 | .7 | .7 | .7 | |
Cleveland: | |||||||||
Ileal | 1.7 | 36.7 | 35.0 | 20.0 | 6.7 | ||||
Colonic | 12.0 | 60.0 | 16.0 | 8.0 | 4.0 | ||||
European: | |||||||||
L1 | 5.0 | 23.3 | 43.3 | 21.7 | 1.7 | 5.0 | |||
L2 | 2.2 | 50.0 | 32.6 | 10.9 | 2.2 | 2.2 | |||
L3 | 8.5 | 32.2 | 35.6 | 15.3 | 5.1 | 3.4 | |||
UC | 5.3 | 33.3 | 33.3 | 14.7 | 9.3 | 2.7 | 1.3 |
Note.— For the number of patients in these subgroups, see table 1.